Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus;Síndrome metabólico, resistencia a la acción de la insulina y enfermedad cardiovascular en la diabetes mellitus tipo 1

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 1, 2010, Pages 125-130

  Rodrigues, Ticiana C ^a,b   Canani, Luis Henrique ^a,b   Gross, Jorge L ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cardiovascular diseases; Diabetes mellitus, type 1; Insulin resistance; Metabolic syndrome

Indexed keywords

FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ALBUMINURIA; ARTERY CALCIFICATION; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC VALUE; DISEASE COURSE; FATTY ACID BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; GOLD STANDARD; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; MICROALBUMINURIA; MORTALITY; OBESITY; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 77951518938     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005; 28:2289-2304
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: finding from the Third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356-359
3. Costa LA, Canani LH, Lisbôa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med. 2004; 21:252-255
4. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24: 683-689
5. Lakka H-M, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288: 2709-2716
6. Gale EA. Should we dump the metabolic syndrome? Yes. BMJ. 2008; 336: 640-641
7. Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, et al. Finn Diane Study Group. Metabolic syndrome in type 1 diabetes. Association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28: 2019-2024
8. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. American Heart Association; American Diabetes Association. Primary prevention of cardiovascular disease in people with diabetes mellitus:a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2007; 30: 162-172
9. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY-Z, Smithline Kinder L, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10 year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications study. Diabetes Care. 2003; 26:1374-1379
10. Stuhldreher WL, Orchard TJ, Ellis D. The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adults population. Diabetes Res Clin Pract. 1992; 17: 99-109.
11. Stuhldreher WL, Becker DJ, Drash AL, Ellis D, Kuller LH, Wolfson SK, et al. The association of waist-hip ratio with diabetes complications in an adult IDDM population. J Clin Epidemiol. 1994; 47: 447-456
12. Alberti KG, Zimmet PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med. 1998; 15: 539-553
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-2752
14. The IDF consensus world definition of the metabolic syndrome. [Accessed 2008 Mar 22]. Available from http://www.idf.org/webdata/docs/IDF-Metas-def- final.pdf.
15. Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84:01-28.
16. Holt RI. International Diabetes Federation Re-defines the Metabolic Syndrome. Diabetes Obes Metab. 2005; 7: 618-620
17. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365:1415-1428
18. DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerosis. Neth J Med. 1997; 50: 191-197
19. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, et al.Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989; 320:703-706
20. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993; 137: 959-965
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419 (Pubitemid 15018832)
22. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes. 1998; 47: 1643-1649
23. De Fronzo, Simon D, Ferranini E. Hepatic and peripheral insulin resistance: a common feature of type 2 and type 1 diabetes mellitus. Diabetologia. 1982; 23: 313-319
24. Willians KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimulate insulin resistance in type 1 Diabetes?Diabetes. 2000; 49: 626-632
25. Olson JC, Erbey JR, Forrest KYZ, Williams K, Becker DJ, Orchard TJ. Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. Metabolism. 2002; 51: 248-254 (Pubitemid 34168241)
26. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12 - year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. The Pittsburgh Epidemiology of Diabetes Complications study experience. Diabetes Care. 2007; 30: 1248-1254
27. Consensus development on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998. Miami, Florida: American Diabetes Association. Diabetes Care.1998; 21: 1551-1559
28. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. Factors influencing the prognosis. Diabetologia. 1978; 14: 371-377
29. Krolewski AS, Kosinski EJ, Warram JH. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes. Am J Cardiol. 1987; 59: 750-755 (Pubitemid 17061281)
30. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991; 81: 1158-1162
31. Soedamah-Muthu SS, Fuler JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High Risk of cardiovascular disease in patients with type 1 diabetes in the U.K: a cohort study using the general practice research database. Diabetes Care. 2006; 29: 798-804. (Pubitemid 44115297)
32. Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, et al. Mortality from heart disease in a cohort of 23.000 patients with insulin-treted diabetes. Diabetologia. 2003; 46: 760-765 (Pubitemid 36831403)
33. McGill HC, McMahan CA, Zieske AW, Tracy RE, Malcolm GT, Herderick BS, et al. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth. Circulation. 2000; 102: 374-379 (Pubitemid 30490673)
34. Tzcu EM, Kapadia SR, Tutar E, Ziada K, Hobbs R, Mccarthy PM, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults. Circulation. 2001; 103: 2705-2710
35. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type 1 diabetes and coronary artery disease. Diabetes Care. 2006; 29: 2528-2538 (Pubitemid 44912266)
36. Price CT, Becker DJ, Costacou T, Miller RG, Orchard TJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia. 2007; 50: 2280-2288 (Pubitemid 47512402)
37. Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 2004; 164: 1917-1924 (Pubitemid 39274363)
38. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J. 1996; 313: 779-784 (Pubitemid 26326878)
39. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ. Are predictors of coronary heart disease and lower extremity arterial disease in type 1 diabetes the same?A prospective study. Atherosclerosis. 2000; 148: 159-169
40. Lehto S, Ronnemaa T, Pyorata K, Laako M. Poor glycaemic control predicts coronary heart disease events in patients with type 1 diabetes without nephopathy. Arterioscler Thromb Vasc Biol. 1999; 19: 1014-1019 (Pubitemid 29177350)
41. Stettler C, Allemann S, Juni P. Glycaemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006; 152: 27-38. (Pubitemid 43974725)
42. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005: 353: 2643-2653
43. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice: Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.. Eur Heart J. 2003; 24: 1601-1610
44. Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM et al. Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes with and without Diabetic Nephropathy. Circulation. 2007; 115: 228-235
45. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barret EJ. Screening for coronary artery disease in patients with diabetes. Diabetes Care. 2007; 30: 2729-2736
46. Soedamah-Muthu SS, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, et al. EURODIAB Prospective Complications Study Group. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care. 2004; 27: 530-537
47. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, et al. Arterial calcification and not lumen stenosis in highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998; 31: 126-133
48. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007; 49: 1860-1870
49. Dabalea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance?The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003; 52: 2833-2839
50. Colhoun HM, Rubens MB, Underwood SR, Fuller JH. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol. 2000; 36: 2160-2167
51. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes. Diabetes. 2000; 49: 1571-1578
52. Davis TME, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study. Diabetes Res Clin Pract. 2007; 78: 412-417
53. Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes. Diabetes Care. 2006; 29: 2701-2707
54. Chatuverdi N, Sjoelie AK, Porta M, Aldington SJ, Fuller JH, Songigi M, et al. The EURODIAB Prospective Complications Study Group. Markers of Insulin Resistance are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes. The EURODIAB Prospective Complications Study. Diabetes Care. 2001; 24: 284-289
55. Orchard TJ, Chang Y-F, Ferrel RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities?Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int. 2002; 62: 963-970 (Pubitemid 35316726)
56. Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy. Eur J Clin Invest. 2002; 32:100-109 (Pubitemid 36232730)
57. Ekstrand AV, Groop PH, Gronhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant. 1998; 13: 3079-3083 (Pubitemid 28534711)
58. Hasslacher C, Stech W, Wahl P, Ritz E. Blood pressure for nephropathy in type 1 (insulin-dependents) diabetes. Diabetologia. 1985; 28: 6-11.
59. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. "Double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care. 2007; 30: 707-712
60. Sibley SD, Palmer JP, Hirsch IB, Brunzell JD. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab. 2003; 88: 3379-3384 (Pubitemid 36877520)
61. Kabadi UM, Vora A, Kabadi M. Hyperinsulinemia and central adiposity. Diabetes Care. 2000; 23: 1024-1025
62. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 1997; 349: 1210-1213
63. De Block CE, De Leeuw IH, Van Gaal LF. Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care. 2005; 28: 1649-1655 (Pubitemid 41340904)
64. Strowic SM, Raskin P. The effect of rosiglitazone on overweight subjects with type 1 diabetes. Diabetes Care. 2005; 28: 1562-1567 (Pubitemid 40923065)
65. Pagano G, Tagliaferro V, Carta Q, Caselle MT, Bozzo C, Vitelli F, et al. Metformin reduces insulin requirement in type 1 (insulin-dependent) diabetes. Diabetologia. 1983; 24: 351-354 (Pubitemid 13092221)
66. Meyer L, Bohme P, Delbachian I, Lehert P, Cugnardey N, Drouin P, et al. The benefits of metformin therapy during continuos subcutaneous insulin infusion treatment of type 1 diabetic patients. Diabetes Care. 2002; 25: 2153-2158 (Pubitemid 41071020)
67. Sarnblad S, Kroon M, Aman J. Metformin s additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol. 2003; 149: 323-329 (Pubitemid 37304703)
68. Hamilton J, Curnmings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 2003; 26: 138-143 (Pubitemid 36929006)
69. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH and the EURODIAB IDDM Complications Study Group. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabetic Medicine. 2001; 18: 786-796
70. Rodrigues TC. Síndrome metabólica, cálcio coronário e homeostase pressórica en pacientes con diabetes mellitus tipo 1. [Tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2008.